��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2004, 30(2) 69-71 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��崯
	��
	Ԥ��
	��
	��
	��
	PubMed
	Article by
	Article by

Ѱ��崯��ơ��ģʽ��Ԥ��

��, ��

ɽ��ʡƤ��Բ��о��, �� 250022

ժҪ��

ϵͳ��Ƥ��̴��/��Ƽ��ʹ��Ѱ��崯��߻�ó��,��ڿ�ͣ��ϵͳ��,��ں��Ʒ��صĲ��֢;��ܸ��Բ��Ӧ��Խ��ٵ��ߵ��Ʒ�,�ɽ�һ��ƻ��ߵ�Ԥ��,ʹ��Ѱ��崯��Ϊ��.

�ؼ���� 崯 �� Ԥ��

Abstract:

Keywords:

�ո�� 2003-04-18 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Engineer L, Bhol KC, Ahmed AR. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris. J Am Acad Dermatol, 2000, 43(6):1049-1057.
[2] Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol, 2000, 42(3):422-427.
[3] Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol, 1999, 135(1):57-61.
[4] Kanwar A J, Kaur S, Thami GP. Long-term efficacy of dexamethasonecyclophosphamide pulse therapy in pemphigus. Dermatology, 2002,204(3):228-231.
[5] Brodsky PA, Petri M, Smith BD, et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med, 1998, 129(12):1031-1035.
[6] Hayag MV, Cohen JA, Kerdel FA. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol, 2000, 43(6):1065-1069.
[7] Takamori K. Recent advances in the treatment of autoimmune bullous diseases. J Dermatol, 2001, 28(11):654-657.
[8] Bystryn JC, Jiao D, Natow S. Treatment of pemphigus with intravenous immunoglobulin. J Am Acad Dermaatol, 2002, 47(3):358-363.
[9] Sami N, Qureshi A, Ruocco E, et al. Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris. Arch Dermatol, 2002, 138(9):1158-1162.
[10] Ahmed AR. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol, 2001,45(5):679-690.
[11] Jolles S. A review of high-dose intravenous immunnglobulin(hdlVIg)in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol, 2001, 26(2):127-131.
[12] Turner MS, Sutton D, Sauder DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol, 2000, 43(6):1058-1064.
[13] Ogata K, Yasuda K, Matsushita M, et al. Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method. J Dermatol, 1999, 26(4):236-239.
[14] Simon JC, Pfieger D, Schopf E. Recent advances in phototherapy.Eur J Dernatol, 2000, 10(8):642-645.

��е��

1��¥��, ��ɽ�.��崯��ƽ�չ[J]. ��Ƥ��Բ�ѧ��־, 2007,33(6): 331-333

2��,��,��,.��򵰰��Ѱ��崯��Ч�۲�[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 215-217

3��,��.��崯[J]. ��Ƥ��Բ�ѧ��־, 2008,34(6): 388-390

4��Ӣ,�ｨ��,.��崯�ķ��ͼ��µ��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(1): 33-35

5�� ۳��.��Ƥ��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(5): 312-314

6��ջݴ� �̲� ʩ�� ۳��.��Դ��Ա�Ƥ�ɽ�֢�鹬��״ϸ��һ��[J]. ��Ƥ��Բ�ѧ��־, 2010,36(2): 66-68

7��ѧ�� Ƽ �Ŵ�.��崯��ƽ̦޺һ��[J]. ��Ƥ��Բ�ѧ��־, 2010,36(2): 114-114

8�� Ӣ Ҷ�ľ�.��ܲ�λ�ļ��崯һ��ϵ[J]. ��Ƥ��Բ�ѧ��־, 2010,36(3): 174-174

9��, ��.��崯��о��չ[J]. ��Ƥ��Բ�ѧ��־, 0,(): 367-369

10��, �Ÿ��.��崯��ѧ�о��½�չ[J]. ��Ƥ��Բ�ѧ��־, 0,(): 370-372

11��Ⱥ��, ��ѧ��У .��崯��ԭ��ӵ��о��չ[J]. ��Ƥ��Բ�ѧ��־, 1994,20(2): 70-72